Concepedia

Matthew Lei

ML

8

Publications

187

Citations

8

H-Index

2019

Active since

Affiliations

Massachusetts General Hospital(Current)

Harvard University

Semmelweis University

Dana-Farber Cancer Institute

Matthew Lei is an author at Massachusetts General Hospital specializing in medicine, immunology, and t cell immunity.

ORCID

Top concepts

Publications per year

2019–2024

8

Publications

8

The Incidence, Risk Factors, and Outcomes With 5-Fluorouracil–Associated Coronary Vasospasm

Amna Zafar, Zsófia D. Drobni, Ramya Mosarla et al. · JACC CardioOncology · 2021 · 66 citations · Full text

Evaluation of the impact of thyroiditis development in patients receiving immunotherapy with programmed cell death-1 inhibitors

Matthew Lei, Angela Michael, Seema Patel et al. · Journal of Oncology Pharmacy Practice · 2019 · 24 citations

The efficacy and safety of cardio-protective therapy in patients with 5-FU (Fluorouracil)-associated coronary vasospasm

Amna Zafar, Zsófia D. Drobni, Matthew Lei et al. · PLoS ONE · 2022 · 22 citations · Full text

Humoral and cellular immunogenicity of SARS-CoV-2 vaccines in chronic lymphocytic leukemia: a prospective cohort study

J. Erika Haydu, Jenny S. Maron, Robert Redd et al. · Blood Advances · 2022 · 21 citations · Full text

, , +18

Next-generation ALK inhibitors are highly active in ALK-positive large B-cell lymphoma

Jacob D. Soumerai, Allison Rosenthal, Shannon Harkins et al. · Blood · 2022 · 17 citations · Full text

, , +14

Rows per page

1–5 of 8